Состояние жесткости магистральных артерий у больных ИБС в сочетании с облитерирующим атеросклерозом нижних конечностей на фоне комплексной терапии Омакором
Н. Л. Костина, Vadim P. Mikhin, М. А. Чернятина et al. · Курский научно-практический вестник "Человек и его здоровье" · 2011
In recent years a new group of drugs ω-3 polyunsaturated fatty acids (Omacor) has been revealed that exerts influence on atherosclerosis. The purpose of our investigation is to study influence of Omacor on arterial stiffness in patients with coronary heart disease and atherosclerosis of lower limbs vessels. The investigation included patients with coronary heart disease combined with atherosclerosis of lower limbs vessels. The main group consisted of 24 persons which in addition to the basic therapy including petoxyphillin were given Omacor in a dose of 1 g per day for 3 months; the control group of 27 persons taking only basic specimens. It has been demonstrated that application of Omacor in patients with coronary heart disease combined with obliterating atherosclerosis of lower limbs vessels increases cardioankle vascular index, optimize pre ejection period and ejection time and decreases augmentation index.
Cited by 0 works.